AC Immune
ACIU
50 hedge funds and large institutions have $139M invested in AC Immune in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 11 closing their positions.
27% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 11
4% more funds holding
Funds holding: 48 → 50 (+2)
1.59% more ownership
Funds ownership: 28.26% → 29.86% (+1.6%)
14% less capital invested
Capital invested by funds: $163M → $139M (-$23.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.72M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.33M |
| 3 |
Renaissance Technologies
New York
|
+$1.48M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.45M |
| 5 |
QI
QS Investors
New York
|
+$966K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Prosight Management
Dallas,
Texas
|
-$1.44M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$485K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$369K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$307K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$287K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TI
51
Trexquant Investment
Stamford,
Connecticut
| – | -$248K | -29,092 | Closed |
|
|
SIM
52
Spark Investment Management
New York
| – | -$205K | -24,083 | Closed |
|
|
HF
53
HRT Financial
New York
| – | -$190K | -22,354 | Closed |
|
|
ECM
54
ExodusPoint Capital Management
New York
| – | -$183K | -21,425 | Closed |
|
55
ProShare Advisors
Bethesda,
Maryland
| – | -$124K | -14,611 | Closed |
|
|
TRCT
56
Tower Research Capital (TRC)
New York
| – | -$68.2K | -8,728 | -100% |
|
57
JP Morgan Chase
New York
| – | -$43K | -5,059 | Closed |
|
|
MWNA
58
Marshall Wace North America
New York
| – | -$29K | -3,374 | Closed |
|
|
LC
59
Lindbrook Capital
Calabasas,
California
| – | -$4K | -500 | Closed |
|
60
Barclays
London,
United Kingdom
| – | -$1K | -134 | Closed |
|
|
CG
61
Cutler Group
San Francisco,
California
| – | +$782 | +100 | New |
|
ACIU Hedge Fund Activity: Q1 2020 in Review
50 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q1 2020, worth a combined $139M — down 14% from $163M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ACIU positions and 11 closed out — a net gain of 3 holders — while 9 added to existing stakes and 20 trimmed.
The largest buyer was Millennium Management, adding an estimated $3.72M. The largest seller was Prosight Management, cutting an estimated $1.44M.
- 50 institutional investors held AC Immune (ACIU) as of Q1 2020, up from 48 in Q4 2019.
- Funds reported $139M of AC Immune stock for Q1 2020, down 14% quarter-over-quarter.
- 14 funds opened new AC Immune positions in Q1 2020 and 11 closed out, a net change of +3 holders.
- The largest AC Immune buyer in Q1 2020 was Millennium Management, an estimated $3.72M added.
- The largest AC Immune seller in Q1 2020 was Prosight Management, an estimated $1.44M sold.
Based on aggregated 13F filings for Q1 2020.